BE878876Q - Medicament a base de derive de piperidino-2 alcanol-1 - Google Patents
Medicament a base de derive de piperidino-2 alcanol-1Info
- Publication number
- BE878876Q BE878876Q BE0/197218A BE197218A BE878876Q BE 878876 Q BE878876 Q BE 878876Q BE 0/197218 A BE0/197218 A BE 0/197218A BE 197218 A BE197218 A BE 197218A BE 878876 Q BE878876 Q BE 878876Q
- Authority
- BE
- Belgium
- Prior art keywords
- alcanol
- piperidino
- derivative medicine
- medicine
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR77770A FR5733M (fr) | 1966-09-27 | 1966-09-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
BE878876Q true BE878876Q (fr) | 1980-03-19 |
Family
ID=8617916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/197218A BE878876Q (fr) | 1966-09-27 | 1979-09-19 | Medicament a base de derive de piperidino-2 alcanol-1 |
Country Status (5)
Country | Link |
---|---|
US (1) | US3509164A (fr) |
BE (1) | BE878876Q (fr) |
DE (1) | DE1695772C3 (fr) |
FR (1) | FR5733M (fr) |
GB (1) | GB1159449A (fr) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2067187B (en) * | 1979-12-07 | 1983-11-30 | Cosmos Enterprise | Process for the preparation of 1-(4-hydroxyphenyl)-2-(4-benzylpiperidino)-1-propanol and acid addition salts thereof |
FR2503705A1 (fr) * | 1981-04-14 | 1982-10-15 | Synthelabo | Derives de phenethanolamine, leur preparation et leur application en therapeutique |
KR840001829A (ko) * | 1981-10-30 | 1984-06-07 | 스즈끼 시개끼 | 새로운 이펜프로딜을 함유하는 정제의 제조방법 |
GR78370B (fr) * | 1981-12-24 | 1984-09-26 | Delalande Sa | |
FR2534580A1 (fr) * | 1982-10-13 | 1984-04-20 | Synthelabo | Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent |
WO1987000433A1 (fr) * | 1985-07-24 | 1987-01-29 | Grelan Pharmaceutical Co., Ltd. | Agent ameliorant la circulation |
US5272160A (en) * | 1989-05-17 | 1993-12-21 | Pfizer Inc | 2-piperidino-1-alkanol derivatives as antiischemic agents |
WO1990014087A1 (fr) * | 1989-05-17 | 1990-11-29 | Pfizer Inc. | Derives de 2-piperidino-1-alcanol en tant qu'agents antiischemiques |
FR2654341B1 (fr) * | 1989-11-14 | 1994-09-23 | Synthelabo | Utilisation d'ifenprodil et de ses derives pour la fabrication de medicaments antipsychotiques. |
HU222726B1 (hu) * | 1990-02-06 | 2003-09-29 | Pfizer, Inc., | Piperidinszármazékok, eljárás elżállításukra és az ezeket tartalmazó gyógyszerkészítmények |
DK0554247T3 (da) * | 1990-05-10 | 2000-08-07 | Pfizer | Neurobeskyttende indolon og beslægtede derivater |
JPH0788355B2 (ja) * | 1991-04-18 | 1995-09-27 | フアイザー・インコーポレイテツド | フェノール性2―ピペリジノ―1―アルカノールのプロドラグエステル |
US5710168A (en) * | 1991-10-23 | 1998-01-20 | Pfizer Inc. | 2-piperidino-1-alkanol derivatives as neuroprotective agents |
US5527912A (en) * | 1991-10-23 | 1996-06-18 | Pfizer Inc. | Intermediates for 2-piperidino-1-alkanol derivatives |
US6255322B1 (en) | 1992-06-19 | 2001-07-03 | Pfizer Inc. | 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents |
US5436255A (en) * | 1992-07-23 | 1995-07-25 | Pfizer Inc. | Method of treating diseases susceptable to treatment by blocking NMDA-receptors |
CZ280669B6 (cs) * | 1992-10-30 | 1996-03-13 | Pfizer Inc. | Deriváty 3,4-dihydro-2(1H)-chinolonu a farmaceutický prostředek na jejich bázi |
US5498610A (en) * | 1992-11-06 | 1996-03-12 | Pfizer Inc. | Neuroprotective indolone and related derivatives |
ATE183184T1 (de) * | 1994-01-31 | 1999-08-15 | Pfizer | Neuroprotektive chroman verbindungen |
FR2722989B1 (fr) | 1994-07-29 | 1997-05-30 | Synthelabo | Utilisation de l'ifenprodil et de ses enantiomeres pour la preparation de medicaments utiles dans le traitement des neuropathies peripheriques et des maladies neurodegeneratives centrales |
US6046213A (en) * | 1994-08-18 | 2000-04-04 | Pfizer Inc. | Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives |
JPH08231400A (ja) * | 1995-02-24 | 1996-09-10 | Rohto Pharmaceut Co Ltd | イフェンプロジルを必須成分とする眼圧降下剤 |
PL340080A1 (en) | 1997-10-24 | 2001-01-15 | Warner Lambert Co | Method of treating disease-related or post-drug dyskinesias |
GB9804885D0 (en) | 1998-03-06 | 1998-04-29 | Merck Sharp & Dohme | Therapeutic combination |
CN1681495B (zh) | 2002-08-19 | 2010-05-12 | 辉瑞产品公司 | 用于治疗过度增生性疾病的组合物 |
US20050037063A1 (en) * | 2003-07-21 | 2005-02-17 | Bolton Anthony E. | Combined therapies |
US20060063803A1 (en) * | 2004-09-23 | 2006-03-23 | Pfizer Inc | 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
JP5498168B2 (ja) | 2006-12-01 | 2014-05-21 | ブリストル−マイヤーズ スクイブ カンパニー | アテローム性動脈硬化および循環器疾患の治療のためのcetp阻害剤としてのn−((3−ベンジル)−2,2−(ビス−フェニル)−プロパン−1−アミン誘導体 |
RU2469023C1 (ru) * | 2011-06-22 | 2012-12-10 | Учреждение Российской академии наук Институт молекулярной генетики РАН (ИМГ РАН) | Равномерно меченный тритием 4-[2-(4-бензилпиперидин-1-ил-гидроксипропил] фенол |
EP2986599A1 (fr) | 2013-04-17 | 2016-02-24 | Pfizer Inc. | Dérivés de n-pipéridin-3-ylbenzamide dans le traitement des maladies cardiovasculaires |
DK3200828T3 (da) | 2014-10-03 | 2020-10-12 | Lachesis Biosciences Ltd | Intranasale sammensætninger til behandling af neurologiske og neurodegenerative sygdomme og forstyrrelser |
WO2016055901A1 (fr) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Composés d'amide substitué |
US10583171B2 (en) | 2015-11-30 | 2020-03-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | NMDAR antagonists for the treatment of diseases associated with angiogenesis |
BR112021013807A2 (pt) | 2019-01-18 | 2021-11-30 | Astrazeneca Ab | Inibidores de pcsk9 e seus métodos de uso |
US20230218644A1 (en) | 2020-04-16 | 2023-07-13 | Som Innovation Biotech, S.A. | Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1915334A (en) * | 1930-10-16 | 1933-06-27 | Du Pont | Fluosilicate of organic heterocyclic bases and process of making it |
US2075359A (en) * | 1930-10-16 | 1937-03-30 | Du Pont | Insecticide |
-
1966
- 1966-09-27 FR FR77770A patent/FR5733M/fr not_active Expired
-
1967
- 1967-09-07 DE DE1695772A patent/DE1695772C3/de not_active Expired
- 1967-09-21 US US669413A patent/US3509164A/en not_active Expired - Lifetime
- 1967-09-25 GB GB43572/67A patent/GB1159449A/en not_active Expired
-
1979
- 1979-09-19 BE BE0/197218A patent/BE878876Q/fr not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE1695772B2 (de) | 1973-11-22 |
DE1695772C3 (de) | 1974-06-20 |
DE1695772A1 (de) | 1972-02-17 |
GB1159449A (en) | 1969-07-23 |
FR5733M (fr) | 1968-01-22 |
US3509164A (en) | 1970-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE878876Q (fr) | Medicament a base de derive de piperidino-2 alcanol-1 | |
CH473591A (de) | Infusionsapparat | |
NL144835C (nl) | Medicinale injecteur. | |
BE776084A (fr) | Injecteurs de medicament | |
CH470878A (de) | Medizinischer Verband | |
FR1491856A (fr) | Cathéter | |
CH441629A (de) | Nasenkanüle | |
AT241340B (de) | Arzneimittelverpackung | |
BE752955A (fr) | Seringue hypodermique | |
NL152455B (nl) | Medicinale spuit. | |
CH476501A (de) | Injektionsspritze | |
AT269361B (de) | Medikamentbehälter | |
CH492607A (de) | Dose | |
CH480843A (de) | Medizinischer Verband | |
FR2004418A1 (fr) | Medicament ferrugineux | |
AT276579B (de) | Patientenlagerungstisch | |
AT273381B (de) | Tablettenspender | |
FR1518125A (fr) | Seringue hypodermique | |
FR5905M (fr) | Medicaments a base de derives de benzodiazepine | |
FR3866M (fr) | Médicament a base de dérivé du pyrocatéchol. | |
AT270076B (de) | Medikamentendosiervorrichtung | |
BE759692A (fr) | Medicament mineralo-vegetal | |
FR1502286A (fr) | Seringue hypodermique | |
CH474270A (de) | Infusionsvorrichtung | |
FR1499738A (fr) | Sucette perfectionnée |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: SYNTHELABO Effective date: 19950930 |